Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
02/08/2023 | UBS Group AG | 12041(L) | -4,011,014(L) | 563,159,475(L) 364,864,831(S) | 14.97 9.70 | |
28/07/2023 | UBS Group AG | 1305(L) | 64,215,500(L) | 566,190,546(L) 364,884,603(S) | 15.05 9.70 | |
27/07/2023 | UBS Group AG | 1306(L) | 41,099,000(L) | 564,975,451(L) 364,525,808(S) | 15.02 9.69 | |
25/07/2023 | UBS Group AG | 1104(L) | +17,409,071(L) | 571,404,451(L) 362,611,293(S) | 15.19 9.64 | |
17/07/2023 | UBS Group AG | 1306(L) | 14,918,900(L) | 540,321,366(L) 362,538,347(S) | 14.36 9.64 | |
14/07/2023 | UBS Group AG | 1205(L) | -22,461,684(L) | 542,475,866(L) 362,538,383(S) | 14.42 9.64 | |
13/07/2023 | UBS Group AG | 1305(L) | 49,407,700(L) | 568,855,046(L) 365,216,941(S) | 15.12 9.71 | |
12/07/2023 | UBS Group AG | 1306(L) | 36,472,900(L) | 570,192,022(L) 367,413,806(S) | 15.16 9.77 | |
11/07/2023 | UBS Group AG | 1104(L) | +27,274,885(L) | 569,736,451(L) 367,391,174(S) | 15.15 9.77 | |
10/07/2023 | UBS Group AG | 1104(L) | +136,534,866(L) | 542,694,590(L) 367,512,793(S) | 14.43 9.77 | |
10/07/2023 | UBS Group AG | 1104(L) | +288,792,900(L) | 694,952,624(L) 367,512,793(S) | 18.47 9.77 | |
03/07/2023 | UBS Group AG | 1201(L) | -8,253,000(L) | HKD3.318(L) | 409,373,380(L) 372,451,793(S) | 10.88 9.90 |
30/06/2023 | Liu Dianbo | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | UBS Group AG | 1201(L) | -68,750,000(L) | HKD3.535(L) | 414,017,118(L) 368,053,174(S) | 11.01 9.78 |
30/06/2023 | Shorea LBG | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | Ginkgo (PTC) Limited | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | Nelumbo Investments Limited | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | Luye Life Sciences Group Ltd | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | Luye Pharma Holdings Ltd. | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
28/06/2023 | UBS Group AG | 1013(L) 1402(S) | +300,554,500(L) +218,500,000(S) | 477,797,810(L) 365,647,890(S) | 12.70 9.72 | |
28/06/2023 | 1001(L) | +6,631,000(L) | HKD3.519(L) | 192,746,000(L) | 5.12 | |
03/05/2023 | Nelumbo Investments Limited | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Nelumbo Investments Limited | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | LuYe Pharmaceutical International Co., Ltd. | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Life Sciences Group Ltd | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Ginkgo (PTC) Limited | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Ginkgo (PTC) Limited | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Pharma Holdings Ltd. | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Pharma Holdings Ltd. | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Shorea LBG | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Liu Dianbo | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Liu Dianbo | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Life Sciences Group Ltd | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Shorea LBG | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
22/02/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
1 2 3 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 28/03/2024 18:00 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |